Bristol Myers Squibb Co (BMY) Holder One Capital Management Lowered Position by $306,714 as Market Value Declined; Bank Amer (BAC) Share Value Declined While Picton Mahoney Asset Management Lowered by $4.47 Million Its Stake

Bristol-Myers Squibb Company (NYSE:BMY) Logo

One Capital Management Llc decreased its stake in Bristol Myers Squibb Co (BMY) by 22.26% based on its latest 2018Q3 regulatory filing with the SEC. One Capital Management Llc sold 4,947 shares as the company’s stock declined 13.60% with the market. The institutional investor held 17,280 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $1.07M, down from 22,227 at the end of the previous reported quarter. One Capital Management Llc who had been investing in Bristol Myers Squibb Co for a number of months, seems to be less bullish one the $78.34 billion market cap company. The stock increased 0.57% or $0.27 during the last trading session, reaching $47.99. About 12.47M shares traded or 2.82% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 14.97% since January 12, 2018 and is downtrending. It has underperformed by 14.97% the S&P500. Some Historical BMY News: 20/03/2018 – Phase III IMpower131 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Reduced; 06/03/2018 – FDA approves new dosing for Bristol-Myers Squibb’s Opdivo; 17/04/2018 – Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2; 09/04/2018 – KEYTRUDA® (pembrolizumab) Monotherapy Met Primary Endpoint in Phase 3 KEYNOTE-042 Study, Significantly Improving OS as First-Line Therapy in Locally Advanced or Metastatic NSCLC Patients Expressing PD-L1 in at Least 1 Percent of Tumor…; 24/04/2018 – Rhode Island DoA: Bristol Warren Regional School District Tue, 4/24/2018, 6:00 PM; 29/05/2018 – ROCHE SAYS PHASE lll IMPOWER130 STUDY SHOWED TECENTRIQ (ATEZOLIZUMAB) PLUS CHEMOTHERAPY HELPED PEOPLE WITH METASTATIC NON-SQUAMOUS NSCLC LIVE SIGNIFICANTLY LONGER COMPARED TO CHEMOTHERAPY ALONE; 29/05/2018 – EXELIXIS REPORTS U.S. FDA ACCEPTS SNDA FOR CABOMETYX® (CABOZANT; 25/05/2018 – IMFINZI® (Durvalumab) Significantly Improves Overall Survival in the Phase III Pacific Trial for Unresectable Stage III Non; 03/05/2018 – BRISTOL-MYERS SQUIBB CO – SHAREHOLDERS ELECTED EACH OF COMPANY’S 12 NOMINEES TO SERVE AS DIRECTORS OF COMPANY UNTIL 2019 ANNUAL MEETING; 16/04/2018 – FDA OKS BRISTOL-MYERS’ NIVOLUMAB PLUS IPILIMUMAB COMBINATION

Picton Mahoney Asset Management decreased its stake in Bank Amer Corp (BAC) by 15.43% based on its latest 2018Q3 regulatory filing with the SEC. Picton Mahoney Asset Management sold 154,053 shares as the company’s stock declined 19.66% with the market. The institutional investor held 844,047 shares of the major banks company at the end of 2018Q3, valued at $24.87 million, down from 998,100 at the end of the previous reported quarter. Picton Mahoney Asset Management who had been investing in Bank Amer Corp for a number of months, seems to be less bullish one the $255.46B market cap company. The stock increased 1.17% or $0.3 during the last trading session, reaching $26.03. About 63.48 million shares traded. Bank of America Corporation (NYSE:BAC) has declined 13.97% since January 12, 2018 and is downtrending. It has underperformed by 13.97% the S&P500. Some Historical BAC News: 16/04/2018 – BANK OF AMERICA – CREDIT CARD DELINQUENCY RATE 1.69 PCT AT MARCH END VS 1.72 PCT AT FEBRUARY END – SEC FILING; 16/03/2018 – BofA’s European Banking President Wilmot-Sitwell Departs Firm; 15/05/2018 – Alkermes Presenting at Bank of America Conference Tomorrow; 11/04/2018 – BofA, Harvard Partner on the Growth, Prosperity of AI (Video); 16/03/2018 – Bank of America to Lose Executive Overseeing Europe; 16/04/2018 – Bank of America 1Q Efficiency Ratio 60%; 27/03/2018 – Dana Inc at Bank of America Merrill Lynch Auto Summit Tomorrow; 26/04/2018 – DealStreetAsia: Bofa not pushing for investment banking for China; 23/03/2018 – SCHNEIDERMAN SAYS UNDISCLOSED AGREEMENTS ENABLED BANK TO CONCEAL FROM CLIENTS OVER FIVE YEARS THAT IT SECRETLY ROUTED THEIR ORDERS FOR EQUITY SECURITIES TO THOSE FIRMS; 15/05/2018 – Amedisys Presenting at Bank of America Conference Tomorrow

One Capital Management Llc, which manages about $676.36 million and $553.04M US Long portfolio, upped its stake in Apple Inc (NASDAQ:AAPL) by 2,403 shares to 37,596 shares, valued at $8.49 million in 2018Q3, according to the filing. It also increased its holding in Wisdomtree Tr by 42,239 shares in the quarter, for a total of 707,221 shares, and has risen its stake in Wisdomtree Tr (DIM).

Among 25 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 8 have Buy rating, 1 Sell and 16 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 100 analyst reports since July 28, 2015 according to SRatingsIntel. The rating was upgraded by BMO Capital Markets on Friday, April 27 to “Market Perform”. Cowen & Co maintained the stock with “Hold” rating in Monday, July 10 report. The company was maintained on Friday, April 29 by UBS. As per Friday, April 20, the company rating was maintained by Cowen & Co. The firm has “Market Perform” rating given on Friday, November 16 by BMO Capital Markets. Citigroup maintained the shares of BMY in report on Tuesday, September 20 with “Buy” rating. UBS maintained the stock with “Buy” rating in Friday, October 6 report. Guggenheim maintained Bristol-Myers Squibb Company (NYSE:BMY) on Tuesday, November 27 with “Hold” rating. The firm earned “Sell” rating on Wednesday, August 16 by BMO Capital Markets. On Monday, November 13 the stock rating was maintained by BMO Capital Markets with “Sell”.

Analysts await Bristol-Myers Squibb Company (NYSE:BMY) to report earnings on January, 24 before the open. They expect $0.84 EPS, up 23.53% or $0.16 from last year’s $0.68 per share. BMY’s profit will be $1.37 billion for 14.28 P/E if the $0.84 EPS becomes a reality. After $1.09 actual EPS reported by Bristol-Myers Squibb Company for the previous quarter, Wall Street now forecasts -22.94% negative EPS growth.

Investors sentiment increased to 0.88 in 2018 Q3. Its up 0.10, from 0.78 in 2018Q2. It increased, as 41 investors sold BMY shares while 532 reduced holdings. 119 funds opened positions while 388 raised stakes. 1.14 billion shares or 0.62% less from 1.14 billion shares in 2018Q2 were reported. Klingenstein Fields And Ltd Liability holds 0.14% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 63,768 shares. South Texas Money Mgmt Limited owns 648,632 shares. Kentucky Retirement holds 0.53% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 135,941 shares. France-based Credit Agricole S A has invested 0.28% in Bristol-Myers Squibb Company (NYSE:BMY). Macquarie Group Limited invested in 187,000 shares or 0.02% of the stock. Burns J W & Ny has 73,301 shares for 1.07% of their portfolio. Livingston Group Incorporated Asset Com (Operating As Southport Cap Management) has 0.2% invested in Bristol-Myers Squibb Company (NYSE:BMY) for 7,513 shares. Dynamic Advisor Solutions Llc owns 23,113 shares. Reilly Advisors Ltd Com invested in 0.01% or 1,537 shares. City Com holds 0.75% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY) for 42,108 shares. M&R Cap Management Inc accumulated 0.4% or 29,844 shares. Van Hulzen Asset Mngmt Ltd Liability reported 6,129 shares stake. First Retail Bank has 27,780 shares. Cambridge Com stated it has 40,016 shares. Ghp Investment reported 4,810 shares.

Investors sentiment decreased to 0.84 in Q3 2018. Its down 0.17, from 1.01 in 2018Q2. It worsened, as 57 investors sold BAC shares while 649 reduced holdings. 123 funds opened positions while 473 raised stakes. 6.37 billion shares or 1.73% less from 6.48 billion shares in 2018Q2 were reported. Moreover, Ironwood Inv Limited Co has 0.23% invested in Bank of America Corporation (NYSE:BAC) for 11,034 shares. Cadence Mngmt Limited Co holds 77,057 shares or 0.12% of its portfolio. Arvest Fincl Bank Trust Division holds 950,680 shares or 1.9% of its portfolio. The Tennessee-based Lbmc Investment Advsr Ltd has invested 0.11% in Bank of America Corporation (NYSE:BAC). Cambridge Inv Rech Advsrs Inc reported 783,611 shares. Buffington Mohr Mcneal accumulated 18,825 shares. 118,978 were reported by Essex Inv Management Company Ltd Liability Corp. Hugh Johnson Advsrs Limited has invested 0.43% in Bank of America Corporation (NYSE:BAC). Univest Of Pennsylvania invested 1.12% in Bank of America Corporation (NYSE:BAC). Cornerstone Advisors Inc holds 1.54% or 724,300 shares. Sandy Spring Bank has 0.22% invested in Bank of America Corporation (NYSE:BAC). California Employees Retirement Sys has 0.83% invested in Bank of America Corporation (NYSE:BAC). Thompson Siegel & Walmsley Lc invested in 0.09% or 246,889 shares. Moreover, Ims Management has 0% invested in Bank of America Corporation (NYSE:BAC). Arlington Value Limited accumulated 278,950 shares.

Picton Mahoney Asset Management, which manages about $1.42B US Long portfolio, upped its stake in Align Technology Inc (NASDAQ:ALGN) by 1,200 shares to 32,900 shares, valued at $12.87 million in 2018Q3, according to the filing. It also increased its holding in Progressive Corp Ohio (NYSE:PGR) by 36,800 shares in the quarter, for a total of 295,800 shares, and has risen its stake in Amazon Com Inc (NASDAQ:AMZN).

Among 33 analysts covering Bank of America (NYSE:BAC), 22 have Buy rating, 0 Sell and 11 Hold. Therefore 67% are positive. Bank of America had 118 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Wednesday, April 12 by BMO Capital Markets. Vetr upgraded it to “Buy” rating and $18.59 target in Monday, August 24 report. CLSA maintained Bank of America Corporation (NYSE:BAC) on Friday, September 23 with “Outperform” rating. Jefferies maintained Bank of America Corporation (NYSE:BAC) rating on Thursday, September 14. Jefferies has “Buy” rating and $28.0 target. The stock has “Neutral” rating by Robert W. Baird on Tuesday, August 25. The firm has “Overweight” rating by Morgan Stanley given on Friday, February 2. Macquarie Research upgraded the stock to “Outperform” rating in Thursday, February 16 report. Robert W. Baird downgraded Bank of America Corporation (NYSE:BAC) on Wednesday, November 16 to “Neutral” rating. The stock has “Buy” rating by Renaissance Macro Securities LLC on Sunday, July 23. The stock has “Buy” rating by KBW on Tuesday, September 1.

Analysts await Bank of America Corporation (NYSE:BAC) to report earnings on January, 16 before the open. They expect $0.63 earnings per share, up 34.04% or $0.16 from last year’s $0.47 per share. BAC’s profit will be $6.18 billion for 10.33 P/E if the $0.63 EPS becomes a reality. After $0.66 actual earnings per share reported by Bank of America Corporation for the previous quarter, Wall Street now forecasts -4.55% negative EPS growth.

More notable recent Bank of America Corporation (NYSE:BAC) news were published by: Fool.com which released: “3 Value Stocks to Absolutely Love During This Correction – The Motley Fool” on December 18, 2018, also Seekingalpha.com with their article: “Bank Of America: Bulls Vs. Bears – Seeking Alpha” published on December 21, 2018, Seekingalpha.com published: “Bank Of America: Tread Carefully – Seeking Alpha” on December 17, 2018. More interesting news about Bank of America Corporation (NYSE:BAC) were released by: Seekingalpha.com and their article: “The Attractiveness Of Bank Of America At $25 Instead Of $12.50 – Seeking Alpha” published on December 13, 2018 as well as Seekingalpha.com‘s news article titled: “Bank Of America: Price Drop May Be An Overreaction – Seeking Alpha” with publication date: December 13, 2018.

Bristol-Myers Squibb Company (NYSE:BMY) Institutional Positions Chart